Hypertriglyceridemia and atherosclerosis

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and it has been confirmed that increased low density lipoprotein cholesterol (LDL-C) is an independent risk factor for atherosclerosis. Recently, the increasing evidence has showed that hypertriglyceridemia is associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jia, Luo, Fei, Ruan, Guiyun, Peng, Ran, Li, Xiangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719571/
https://www.ncbi.nlm.nih.gov/pubmed/29212549
http://dx.doi.org/10.1186/s12944-017-0625-0
_version_ 1783284519082655744
author Peng, Jia
Luo, Fei
Ruan, Guiyun
Peng, Ran
Li, Xiangping
author_facet Peng, Jia
Luo, Fei
Ruan, Guiyun
Peng, Ran
Li, Xiangping
author_sort Peng, Jia
collection PubMed
description Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and it has been confirmed that increased low density lipoprotein cholesterol (LDL-C) is an independent risk factor for atherosclerosis. Recently, the increasing evidence has showed that hypertriglyceridemia is associated with incremental ASCVD risk. But the proatherogenic mechanism of triglyceride (TG) remains unclear. Therefore, this article focuses on the clinical studies and proatherogenic mechanism related to hypertriglyceridemia, in order to provide reference for the prevention and treatment of ASCVD.
format Online
Article
Text
id pubmed-5719571
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57195712017-12-08 Hypertriglyceridemia and atherosclerosis Peng, Jia Luo, Fei Ruan, Guiyun Peng, Ran Li, Xiangping Lipids Health Dis Review Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and it has been confirmed that increased low density lipoprotein cholesterol (LDL-C) is an independent risk factor for atherosclerosis. Recently, the increasing evidence has showed that hypertriglyceridemia is associated with incremental ASCVD risk. But the proatherogenic mechanism of triglyceride (TG) remains unclear. Therefore, this article focuses on the clinical studies and proatherogenic mechanism related to hypertriglyceridemia, in order to provide reference for the prevention and treatment of ASCVD. BioMed Central 2017-12-06 /pmc/articles/PMC5719571/ /pubmed/29212549 http://dx.doi.org/10.1186/s12944-017-0625-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Peng, Jia
Luo, Fei
Ruan, Guiyun
Peng, Ran
Li, Xiangping
Hypertriglyceridemia and atherosclerosis
title Hypertriglyceridemia and atherosclerosis
title_full Hypertriglyceridemia and atherosclerosis
title_fullStr Hypertriglyceridemia and atherosclerosis
title_full_unstemmed Hypertriglyceridemia and atherosclerosis
title_short Hypertriglyceridemia and atherosclerosis
title_sort hypertriglyceridemia and atherosclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719571/
https://www.ncbi.nlm.nih.gov/pubmed/29212549
http://dx.doi.org/10.1186/s12944-017-0625-0
work_keys_str_mv AT pengjia hypertriglyceridemiaandatherosclerosis
AT luofei hypertriglyceridemiaandatherosclerosis
AT ruanguiyun hypertriglyceridemiaandatherosclerosis
AT pengran hypertriglyceridemiaandatherosclerosis
AT lixiangping hypertriglyceridemiaandatherosclerosis

Ejemplares similares